Neurocognitive Testing in Long COVID and Postural Tachycardia Syndrome Patients with Normal Saline: a Pilot Study
Patients with Postural Orthostatic Tachycardia Syndrome (POTS) and Post-Acute Sequelae of COVID (PASC, or Long COVID) experience cognitive dysfunction. The investigators will test the hypothesis that 999 mL of IV saline will improve cognitive function in patients with POTS and Long COVID compared to placebo (50 mL of saline).
• Patients with diagnosis of Long COVID
• SARS-COV2 test positive
• Symptoms \> 12 weeks post COVID
• Subjective complaint of 'brain fog or cognitive dysfunction
• Patients with diagnosis of Postural Orthostatic Syndrome (POTS) from the Calgary Autonomic Investigation and Management Clinic
• Subjective complaint of 'brain fog or cognitive impairment
• Healthy participants
• Without POTS or brain fog
• Age 18 to 60 years
• Female and Male
• Able to give an informed consent